Provider of Information Technology and Big Data Services in the Field of Hospital Economic Operation Management
VCBeat has learned that XISOFT has successfully completed its Series C financing round. The round was led by Shunwei Capital, with SAIF Partners participating as a co-investor. The funds raised will be primarily used for the in-depth development of its “Hospital Operations Data Center (ODR)” product, as well as for the research, development, and promotion of AI-based products and applications, thereby accelerating the digital and intelligent transformation of the healthcare industry.
Founded in 2018, XISOFT is a leading provider of digital and intelligent operational management solutions for China’s healthcare industry. Leveraging its independently developed XiCloud Platform (an intelligent management PaaS platform), the company embodies its product philosophy through six core features: platform-based service aggregation, digital operational management, integrated business-finance convergence, group-level business collaboration, mobile online services, and AI-driven business empowerment. XISOFT offers a “Six-Product System” tailored to the healthcare sector, comprising: the Next-Generation Hospital Intelligent Operational Management System (HRP), the Operational Data Repository (ODR), Performance Management Consulting and Informatics, the Health Economics Regulatory Cloud, Intelligent Logistics Support, and DRG/DIP Intelligent Management. Headquartered in Shanghai, XISOFT has established three R&D centers in Beijing, Shanghai, and Xi’an, with R&D investments exceeding hundreds of millions of yuan. The company maintains branches across all provinces, autonomous regions, and municipalities in China, with a marketing and service network covering the entire country. Its products have been successfully deployed in hundreds of large Grade-A tertiary hospitals and health administrative authorities nationwide, empowering healthcare institutions to achieve “digital and intelligent operations and lean management” through advanced technology and services, thereby facilitating high-quality development in the healthcare industry. In addition to Shunwei Capital and SAIF Partners, the two new investors added in this financing round, XISOFT’s shareholders also include several well-known investment institutions such as Sherpa Investments, Sequoia China, Taikang Life Insurance, Gaorong Capital, and Longma Peak Ventures.
About Shunwei Capital
Shunwei Capital was founded in 2011 by Mr. Lei Jun and Mr. Xu Dalai. Shunwei Capital focuses on deep technology, intelligent manufacturing, Internet Plus, smart hardware, consumer sectors, enterprise services, the electric vehicle ecosystem, and other areas. Its representative domestic and international investment portfolio includes over 600 outstanding companies such as Xiaomi Corporation, Ninebot, Southchip Technology, iQIYI, NIO, Roborock, and Lalamove. By investing in visionary enterprises from the early to growth stages, Shunwei Capital aims to make our lives better.
About SAIF Partners
SAIF Partners (formerly known as Softbank Asia Infrastructure Fund/SoftBank SAIF, renamed SAIF Partners in 2009) is a leading private equity firm providing financial support to high-growth enterprises in the Asia-Pacific region. It focuses on investing in early-stage and growth-stage high-tech companies in China and India, and is one of the earliest large-scale equity investment fund management platforms in China. SAIF currently manages U.S. dollar and RMB funds with a total scale of approximately RMB 40 billion.